Academic or other sponsor

NYU Langone Health

11 registered trials on this registry, 3 recruiting now. An academic sponsor is usually answering a scientific question rather than seeking approval, which changes what its trials are designed to show.

Registered trials

Recruiting

In Phase 3

With results posted

Working on

Substances

Trials

All 11 trials

Trial	Status	Phase	Substance	Sites
Psilocybin Therapy in Advanced CancerNCT05398484 · NYU Langone Health	Recruiting	Phase 2 / Phase 3	psilocybin	2
Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUDNCT06349083 · NYU Langone Health	Recruiting	Phase 2	psilocybin	1
Psilocybin for Opioid Use Disorder (OUD)NCT06796062 · NYU Langone Health	Recruiting	Phase 2	psilocybin	5
Study on the Use of Low Dose Ketamine After Gastric Bypass and GastrectomyNCT02452060 · NYU Langone Health	Completed	Phase 2 / Phase 3	ketamine	1
Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who StutterNCT07296328 · NYU Langone Health	Not yet recruiting	Phase 2	psilocybin	1
A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol DependenceNCT02061293 · NYU Langone Health	Completed	Phase 2	psilocybin	2
Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department PatientsNCT02106325 · NYU Langone Health	Completed	Phase 2	ketamine	2
Psilocybin as a Novel Therapy for Residual AnhedoniaNCT07607938 · NYU Langone Health	Not yet recruiting	Phase 1	psilocybin	1
The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious ProfessionalsNCT02421263 · NYU Langone Health	Completed	Phase 1	psilocybin	1
Psilocybin-Assisted Psychotherapy in Treating Irritable Bowel Syndrome (IBS)NCT06760533 · NYU Langone Health	Not yet recruiting	Early Phase 1	psilocybin	1
Psilocybin Cancer Anxiety StudyNCT00957359 · NYU Langone Health	Completed	Early Phase 1	psilocybin	1

Sponsor attribution is the lead sponsor recorded on ClinicalTrials.gov API v2. Collaborators are not counted here. Data build 2026-08-25.